March 16 GLSA | FOCM Networking Event Recap
On March 16, GLSA and FOCM hosted an online life sciences networking event focused on technology-driven approaches to modern clinical trials. As with each monthly session, the event opened with a featured presenter sharing insights during a brief, focused discussion.
Featured Presentation: Decentralized Clinical Trial Technology
This event featured Wessam Sonbol, Founder of Delve Health, who brings more than 23 years of experience in clinical research, including leadership roles in technology and product development. He founded Delve Health in 2018 to address growing challenges in trial execution through innovative, patient-centered technology.
During his presentation, Wessam outlined how Delve Health supports decentralized and hybrid clinical trials. The company’s solutions include ePRO and eCOA, eConsent, study task management, wearable and biosensor integration, EMR data collection, and real-world evidence capabilities. Together, these tools are designed to improve trial efficiency while enhancing the experience for patients, caregivers, investigators, and sponsors.
Discussion and Networking
Following the presentation, attendees participated in an interactive Q&A session. Newer participants then introduced themselves, shared their professional backgrounds, and discussed how the group could provide support or connections moving forward.
Event Attendees
-
Wessam Sonbol, Delve Health
-
Andrew Mulchinski, Symbio Research
-
Ravipal Luthra, University of Miami, Miller School of Medicine
-
Heather Hollick, Rizers LLC; Author of Helpful: A Guide to Life, Careers, and the Art of Networking
-
Michael Young, biomedwoRx | Life Sciences Consulting
-
Mike O’Gorman, Life Science Marketplace
-
Edwin Gershom, Noble Life Sciences
Global Life Sciences Alliance
-
Taylor Biche
-
Holly Cliffe
-
Todd Neilson
-
Hannah Lloyd
-
Denise McNerney
-
Joe Buser
-
Zulma Varela
-
Sally Haller
✨ Each month features a special guest speaker, so don’t miss these ongoing GLSA | FOCM networking events.
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.